Pooled analysis from 3 PSA+12 PSO trials on ixekizumab RCTs. Reassuring that incidence of IBD relatively low with significant pt year f/u (https://t.co/icWfGIEnxt @RheumNow #ACR18
Links:
Incidence of Inflammatory Bowel Disease Among Patients Treated with Ixekizumab:…
https://acrabstracts.org/abstract/incidence-of-inflammatory-bowel-disease-among…
Oct-24-2018
